EUVIMEDEUVIMED entdecken
Crossref

Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer

Si Chen, HaiBin Wang, Meixu Lei, Yumin Li, Qi Wang, Hengxin Wang, Yifei Shen, Xuejie Su, Yali Zhou iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Si Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, CD8-Positive T-Lymphocytes, Gallic Acid, Adenocarcinoma. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Cuiying Scientific and Technological Innovation Program of the Second Hospital and Clinical Medical School, Lanzhou University, Gansu Natural Science Foundation, Natural Science Foundation of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effect of gallic acid (GA) monomer on the cytotoxic function of tumour-infiltrating CD8+ T cells in gastric cancer and explore the underlying mechanisms.

Methods

Tumour-infiltrating CD8+ T cells were isolated from tumour tissues of patients with gastric adenocarcinoma using fluorescence-activated cell sorting. The purified CD8+ T cells were then co-incubated with GA at five different concentrations (0, 1, 2, 4, and 8 μM) for two incubation periods (24 and 48 h). Subsequently, the cytotoxic activity of tumour-infiltrating CD8+ T cells against gastric cancer cells was assessed using high-content live-cell tracking and cell counting assays. The apoptosis rates of gastric cancer cells were measured, and the expression of apoptosis-related factors caspase-3(p17), Bax, and Bcl-2 was analysed at both the transcriptional and protein levels. Additionally, secretion of IL-2, IL-4, IL-6, IFN-γ, TNF-α, and IL-17 by tumour-inflitrating CD8+ T cells was evaluated to elucidate the potential mechanisms of GA-mediated immunomodulation. Key findings GA significantly enhanced the tumour-killing capacity of tumour-infiltrating CD8+ T cells (cell viability: 51.64% in the intervention group vs. 100% in the control group at 48 h), leading to increased gastric cancer cell apoptosis (apoptotic rate: 38.81% in the intervention group vs. 15.19% in the control group). Western blot and qRT-PCR results showed that the apoptosis executor, caspase-3(p17), and apoptotic molecular switch, Bax, were increased, while the anti-apoptotic protein, Bcl-2, was decreased. The augmented cytotoxicity of tumour-infiltrating CD8+ T cells was associated with statistically significant elevated secretions of pro-inflammatory cytokines Interferon-γ (IFN-γ) (3.97 pg/ml in the intervention group vs. 3.12 pg/ml in the control group), Tumor Necrosis Factor-α (TNF-α) (4.45 pg/ml in the intervention group vs. 3.88 pg/ml in the control group), and Interleukin-2 (IL-2) (5.82 pg/ml in the intervention group vs. 5.22 pg/ml in the control group). In contrast, the expression of IL-17A (43.74 pg/ml in the intervention group vs. 49.38 pg/ml in the control group) and IL-6 (4.13 pg/ml in the intervention group vs. 4.61 pg/ml in the control group) showed statistically significant decreases.

Conclusion

GA restored the impaired cytotoxic function of tumour-infiltrating CD8+ T cells in gastric cancer. These findings position GA as a potential novel immunomodulatory agent for improving anti-tumour immunity in gastric cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCD8-Positive T-LymphocytesGallic AcidAdenocarcinomaLymphocytes, Tumor-InfiltratingHumansApoptosisCell Line, TumorCytokinesCaspase 3Proto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinMaleFemale

Stichwörter der Autor:innen

apoptosiscytokinesgallic acidtumour-infiltrating CD8+ T cells

Substanzen

Gallic AcidCytokinesCaspase 3Proto-Oncogene Proteins c-bcl-2bcl-2-Associated X Protein

Autor:innen und Institutionen

  • Laboratory Medicine Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China.
  • CuiYing Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China.
  • Gansu Province Key Laboratory of Environmental Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China.

ORCID-Profile: Yali Zhou

Förderung

  • Cuiying Scientific and Technological Innovation Program of the Second Hospital and Clinical Medical School, Lanzhou University
  • Gansu Natural Science Foundation
  • Natural Science Foundation of Gansu Province
  • Cuiying Scientific Research, and Cultivation Program of the Second Hospital

Zitieren

APA

Chen, S., Wang, H., Lei, M., Li, Y., Wang, Q., Wang, H., Shen, Y., Su, X., & Zhou, Y. (2026). Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf087

Vancouver

Chen S, Wang H, Lei M, Li Y, Wang Q, Wang H, et al. Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf087

BibTeX
@article{Chen2026,
  author = {Chen, Si and Wang, HaiBin and Lei, Meixu and Li, Yumin and Wang, Qi and Wang, Hengxin and Shen, Yifei and Su, Xuejie and Zhou, Yali},
  title = {Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf087}
}
Kostenlos starten →